Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma
- PMID: 24811831
- DOI: 10.1097/MCP.0000000000000065
Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma
Abstract
Purpose of review: This review gives a comprehensive overview on recent developments in the classification of neoplastic lung lesions with lepidic growth patterns, comprising the adenocarcinoma (ADC) precursor lesions atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), and minimally invasive adenocarcinoma (MIA) as well as lepidic predominant adenocarcinoma (LPA).
Recent findings: The concept of a continuum between the precursor lesions AAH and AIS to MIA and frankly invasive ADC is backed by a wealth of recent data showing a gradual decrease in overall survival from 100% for AAH, AIS, and MIA to moderately lower rates for LPA. Further, it has been shown that the morphologic categorization of these tumors can be done with reasonable reliability and that nonmucinous lepidic tumors show distinct molecular alterations with high rates of epidermal growth factor receptor mutations. Importantly, lepidic tumor growth is also mirrored by specific characteristics in computed tomography images, arguing for a combined assessment of histomorphology and imaging data for an optimized classification of lepidic neoplasms.
Summary: The validity and clinical importance of the novel concept of ADC precursor lesions and LPA have been confirmed by clinical, radiological, morphological, and molecular data. Thereby, it has evolved into a valuable tool to aid in clinical decision-making.
Similar articles
-
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.J Thorac Oncol. 2016 Aug;11(8):1204-1223. doi: 10.1016/j.jtho.2016.03.025. Epub 2016 Apr 21. J Thorac Oncol. 2016. PMID: 27107787 Review.
-
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.Clin Lung Cancer. 2016 Sep;17(5):e57-e64. doi: 10.1016/j.cllc.2016.03.009. Epub 2016 Mar 30. Clin Lung Cancer. 2016. PMID: 27137345 Review.
-
Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.Am J Surg Pathol. 2014 Apr;38(4):448-60. doi: 10.1097/PAS.0000000000000134. Am J Surg Pathol. 2014. PMID: 24472852 Free PMC article.
-
Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.Med Sci (Basel). 2022 Jun 22;10(3):34. doi: 10.3390/medsci10030034. Med Sci (Basel). 2022. PMID: 35893116 Free PMC article.
-
Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.Lung Cancer. 2016 Oct;100:53-62. doi: 10.1016/j.lungcan.2016.07.024. Epub 2016 Jul 27. Lung Cancer. 2016. PMID: 27597281
Cited by
-
Case report: Targeted sequencing facilitates the diagnosis and management of rare multifocal pure ground-glass opacities with intrapulmonary metastasis.Front Oncol. 2024 Jan 23;13:1276095. doi: 10.3389/fonc.2023.1276095. eCollection 2023. Front Oncol. 2024. PMID: 38322291 Free PMC article.
-
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma.Mod Pathol. 2023 Dec;36(12):100326. doi: 10.1016/j.modpat.2023.100326. Epub 2023 Sep 9. Mod Pathol. 2023. PMID: 37678674 Free PMC article.
-
Dual-energy CT-based radiomics for predicting invasiveness of lung adenocarcinoma appearing as ground-glass nodules.Front Oncol. 2023 Aug 10;13:1208758. doi: 10.3389/fonc.2023.1208758. eCollection 2023. Front Oncol. 2023. PMID: 37637058 Free PMC article.
-
Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study.Front Oncol. 2022 Sep 2;12:976988. doi: 10.3389/fonc.2022.976988. eCollection 2022. Front Oncol. 2022. PMID: 36119540 Free PMC article.
-
Emerging role of different DNA methyltransferases in the pathogenesis of cancer.Front Pharmacol. 2022 Aug 25;13:958146. doi: 10.3389/fphar.2022.958146. eCollection 2022. Front Pharmacol. 2022. PMID: 36091786 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
